Android
Nokia
Windows
Published on Fri, Mar 19, 2010 at 15:29 | Source : CNBC-TV18
Updated at Fri, Mar 19, 2010 at 15:34
RELATED NEWS
ALSO READ
Pay-for-delay ban is likely to be dropped from the US Healthcare Bill, reports CNBC-TV18. The provision was to bar out-of-court patent settlements.
The Federal Trade Commission (FTC) had sought curbs on out-of-court deals. It had proposed this provision in consumer interest.
Ranbaxy Laboratories , Lupin , Dr Reddy Laboratories , and Glenmark Pharmaceuticals are involved in patent litigations. The Healthcare Bill is to be voted over the weekend in the US Congress.
PREVIOUS STORY
Buy Gujarat State Petronet; target of Rs 104: Emkay
NEXT STORY
All asset classes to rally if Germany gives in: Uday Kotak
Fans beaten up as Mamata steals the KKR show
PM Says Sharp Fall Of Rupee Is A Matter Of Concern
May 29 2012, 15:22
Infosys good for long term, positive on HCL Tech: Citi
- in FII View
May 29 2012, 12:19
Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart
- in Brokerage Results Estimates
May 29 2012, 17:34 | Source: CNBC-TV18
Will raise Rs 250cr via ECB route next year: Hind Copper
May 29 2012, 15:44 | Source: CNBC-TV18
Improving priority sector lending norms main focus: IDBI
Subscribe to
Moneycontrol Newsletters
Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!
